Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rafael Holdings Inc (RFL)

Rafael Holdings Inc (RFL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data

RFL : 1.9400 (-3.00%)
Rafael Holdings Reports Third Quarter Fiscal 2025 Financial Results

RFL : 1.9400 (-3.00%)
Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering

RFL : 1.9400 (-3.00%)
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential...

RFL : 1.9400 (-3.00%)
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

RFL : 1.9400 (-3.00%)
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™

RFL : 1.9400 (-3.00%)
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role

RFL : 1.9400 (-3.00%)
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals

CYTH : 0.7206 (+1.39%)
RFL : 1.9400 (-3.00%)
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results

CYTH : 0.7206 (+1.39%)
RFL : 1.9400 (-3.00%)
Rafael Holdings, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Updates on Planned Merger with Cyclo Therapeutics

Rafael Holdings reports Q1 fiscal 2025 results, anticipates merger with Cyclo Therapeutics, and focuses on Trappsol® Cyclo™ development.Quiver AI SummaryRafael Holdings, Inc. reported its financial...

RFL : 1.9400 (-3.00%)

Barchart Exclusives

CoreWeave Stock Is Too ‘Expensive’ According to Analysts. Should You Sell CRWV Now?
CoreWeave’s breakout debut this year has dazzled investors, but with valuation concerns now in play, should investors sell this AI stock now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar